Daniel Neureiter
Salzburg, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 200 publications
Emerging claudin-18.2 antagonists in the treatment of biliary tract cancer.
Journal: Expert opinion on emerging drugs
Published: June 03, 2026
Prognostic Factors in Patients with Peritoneal Mesothelioma Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis.
Journal: Annals of surgical oncology
Published: May 21, 2026
The evolution of cancer therapeutics: from "undruggable" to "drugged".
Journal: Translational cancer research
Published: April 06, 2026
Translating Fibrosis to Malignancy: Biomarkers and Therapeutic Opportunities in Liver Fibrosis and Hepatocellular Carcinoma.
Journal: Medical sciences (Basel, Switzerland)
Published: January 07, 2026
Clinical Endoscopic Submucosal Dissection of Trainees Tutored by Experts-ESGE Endorsed Courses and Live Endoscopic Events 2011-2015.
Journal: Journal of clinical medicine
Published: November 25, 2025
Targeted therapy for biliary tract cancer: facts and fictions as well as demands and challenges.
Journal: Expert review of anticancer therapy
Published: November 25, 2025
Impact of Fusobacterium nucleatum on immune cell interactions and gene expression in colorectal cancer: a retrospective cohort study.
Journal: Frontiers in immunology
Published: May 15, 2025
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugates.
Journal: Expert opinion on pharmacotherapy
Published: April 17, 2025
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical study.
Journal: Journal of gastrointestinal oncology
Published: March 08, 2025
Last Updated: 09/26/2026